SpentaGen employs a multi-omics approach to decode the complexity of biological systems. By integrating genomics, transcriptomics, proteomics, and metabolomics, we generate comprehensive molecular profiles that reveal disease mechanisms, identify novel biomarkers, and uncover therapeutic targets. Our team applies advanced bioinformatics and machine learning to analyze large-scale datasets, enabling personalized medicine strategies and accelerating translational research. We believe that the future of healthcare lies in the integration of data — and we are committed to turning that data into actionable insights.
Genomics & Whole-Genome Sequencing
Understanding the complete genetic blueprint.
We perform high-throughput sequencing of entire genomes to identify mutations, structural variants, and genetic markers associated with diseases, traits, and drug responses. Our analyses support both basic research and clinical applications in personalized medicine.
Transcriptomics & Gene Expression Profiling
Mapping the active players in the cell.
By measuring RNA levels across tissues, conditions, or time points, we capture the dynamic expression of genes. This helps us understand how cells respond to environmental changes, disease states, or therapeutic interventions.
Proteomics & Post-Translational Modifications
Decoding the functional output of the genome.
We analyze the full set of proteins expressed in a cell, including their abundance, interactions, and chemical modifications (e.g., phosphorylation, ubiquitination). These modifications regulate protein activity and are critical in signaling, cancer, and drug action.
Metabolomics & Metabolic Pathway Analysis
Capturing the chemical fingerprints of cellular processes.
We profile small molecules (metabolites) to understand metabolic pathways and their perturbations in disease. This approach links genotype to phenotype and helps identify biomarkers, drug targets, and metabolic vulnerabilities.
Single-Cell & Spatial Omics
Zooming in on individual cells — in their tissue context.
These technologies allow us to study gene expression and protein profiles at the single-cell level while preserving spatial organization within tissues. This is essential for understanding tumor heterogeneity, immune microenvironments, and developmental biology.
AI-Driven Biomarker Discovery
Mining data for early detection and diagnosis.
We apply advanced machine learning algorithms to large-scale omics datasets to identify molecular signatures that can predict disease onset, progression, or treatment response. Our goal is to accelerate the development of robust, clinically actionable biomarkers.
Translational Omics for Precision Medicine
Bringing omics from bench to bedside.
We focus on converting omics findings into practical tools for clinicians — such as diagnostic panels, prognostic tests, and companion diagnostics. Our work aims to enable more precise, individualized treatment strategies that improve patient outcomes.
